Journal of Leukemia (JLU) is a peer reviewed medical journal that includes a wide range of fields in Leukemia, Multiple Myeloma, Acute Lymphoblastic Leukemia, Acute Myleoid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myleloid Leukemia, Hairy Cell Leukemia, Pediatric Leukemia, Leukemia drugs, Stem Cell Transplant, Plasma cell Leukemia, Mast cell Leukemia, Lymphoma Cancer, Lymphoma Symptoms, Spleen cancer, Acute Myelomonocytic Leukemia, Aleukemic Leukemia , Lymphosarcoma, Megakaryocytic Leukemia, Feline Leukemia complex, Epidemiologic studies and other Hematologic malignancies and creates a platform for the authors to make their contribution towards the journal and the editorial office promises peer process for the submitted manuscripts to ensure quality.
Leukemia is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of Original articles, Review articles, Case reports, Short communications, etc. in the field and provides free online access to the researchers worldwide.
This scholarly open access journal is using Editorial Manager System for online manuscript submission, review and the progress of the article. Editorial board members of Journal of Leukemia or outside experts review manuscripts; at least two independent reviewer’s approval followed by the ditor is required for the acceptance of any citable manuscript.
Submit manuscript at http://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at firstname.lastname@example.org
Leukemia is malignancy of the white platelets. White platelets help your body battle disease. Your platelets shape in your bone marrow. In leukemia, the bone marrow produces anomalous white platelets. These cells group out the sound platelets, making it hard for blood to do its work. Leukemia may influence red platelets, white platelets, and platelets.
Acute Lymphoblastic Leukemia is a disease of the blood and bone marrow in which the bone marrow makes an excess of juvenile lymphocytes (a kind of white platelet). Acute lymphocytic leukemia is the most widely recognized sort of growth in kids.
AML, also called acute myelogenous leukemia involves the rapid growth of myeloid cells. It occurs in both adults and children and affects about 18,000 people each year in the U.S.
Chronic Lymphocytic Leukemia (CLL) is a slow-growing cancer of lymphoid cells that usually affects people over 55 years of age. It is estimated to affect about 16,000 people in the U.S. every year. It almost never occurs in children or adolescents.
Chronic Myleloid Leukemia also known as chronic myelogenous leukemia primarily affects adults and occurs in about 6,000 people every year in the U.S.
Hairy cell Leukemia (HCL) is an unusual and a rare, slow-growing cancer of the blood. It affects B cells, a type of white blood cell (lymphocyte).
Leukemia is the most commonly diagnosed cancer in children, accounting for about 30% of all cases. The incidence peaks at age 3 years in boys and at 2 years in girls. Approximately 1 in 2,000 children will develop it before the age of 15 years.
Chemotherapy is the standard treatment for many types of leukemia. Even when a cure isn't possible, chemotherapy may help you live longer and feel better.
A stem cell transplant (sometimes called a bone marrow transplant) is a medical procedure in which diseased bone marrow is replaced by highly specialized stem cells that develop into healthy bone marrow.
Plasma cell Leukemia (PCL) is a rare variant of multiple myeloma which is associated with a poor prognosis, with a shorter survival than that of patients presenting with typical multiple myeloma.
Mast cell Leukemia is form marked by overwhelming numbers of tissue mast cells in the peripheral blood.
Lymphoma or lymphatic cancer is thus the term given to the group of cancers in the lymphatic system, occurring when some of the white immune cells, called lymphocytes, become abnormal and malignant.
The most common symptom of lymphoma is a painless swelling in a lymph node, usually in the armpit, groin or neck. This is caused by the damaged lymphocytes collecting in that node. The swelling may also ache.
The spleen is a lymphatic organ and has numerous functions in the body including filtering the blood and producing immune cells such as white blood cells. There are a number of different types of spleen cancers including lymphoma, non-Hodgkin's lymphoma and some types of T-cell lymphomas. Roughly 70,000 new cases of lymphoma are diagnosed each year in the US.
Acute Myelomonocytic Leukemia one of the more common types of acute myelogenous leukemia, characterized by both malignant monocytes and myeloblasts; it usually affects middle aged to older adults.
Aleukemic Leukemia is a leukemia in which the leukocyte count is normal or below normal; it may be lymphocytic, monocytic, or myelocytic.
It is a form with numerous megakaryocytes in the spleen, bone marrow, and other tissues, but decreased numbers or abnormal thrombocytes in the peripheral blood, and anemia. Reported in dogs and cats. Called also megakaryocytic myelosis.
Feline Leukemia is the array of diseases associated with infection of cats by the feline leukemia virus; includes lymphoreticular neoplasms, myelodysplastic disorders and abnormalities of the immune system.
Lymphosarcoma is a malignant tumor in lymphatic tissue, caused by the growth of abnormal lymphocytes. It is a malignant disease of the lymphoid tissues characterized by proliferation of atypical lymphocytes and their localization in various parts of the body. The jaws may be the sites of lymphosarcomas.
OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences annually all over the world. OMICS Publishing Group journals have over 10 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50000 eminent personalities that ensure a rapid, quality and quick review process. OMICS Group signed an agreement with more than 1000 International Societies to make healthcare information Open Access. OMICS Group Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations.
Journal of Leukemia is supporting the 5th World Conference on Cancer Therapy during september 28-30, 2015 Atlanta, USA with the theme of Exploring the Possibilities towards cancer treatment.